Tag: Chemotherapy

ctDNA-based detection of molecular residual disease in response to adjuvant chemotherapy prognostic of outcomes

Increased radiation with SABR boost seems to enhance local control but with reduced overall survival at highest dose

Skipping adjuvant regional nodal irradiation does not increase risk for recurrence or death after neoadjuvant chemo before breast-conserving surgery

Black patients have increased mortality in refractory, sensitive disease; Asians have lower risk in refractory, sensitive, very sensitive disease

Greater incidence of grade 3 or higher adverse events from any cause seen in combination group versus monotherapy

Improvement in overall survival seen for patients receiving cisplatin or carboplatin with pemetrexed

Pretreatment vitamin D insufficiency linked to increased incidence of grade ≥3 chemotherapy-induced peripheral neuropathy

Improvement seen in progression-free survival with add-on pembrolizumab in gastroesophageal junction adenocarcinoma

Overall, 72 and 59 percent of 26 cancer centers reported shortages in carboplatin and cisplatin

Clinical complete response of 43 percent seen for those with muscle-invasive bladder cancer receiving neoadjuvant gemcitabine, cisplatin, plus nivolumab